232 related articles for article (PubMed ID: 34807495)
1. Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitis.
Zengarini C; Pileri A; Salamone FP; Piraccini BM; Vitale G; La Placa M
J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e179-e180. PubMed ID: 34807495
[No Abstract] [Full Text] [Related]
2. Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine.
Joseph AK; Chong BF
Dermatol Ther; 2021 Nov; 34(6):e15114. PubMed ID: 34455671
[No Abstract] [Full Text] [Related]
3. Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination.
Kreuter A; Burmann SN; Burkert B; Oellig F; Michalowitz AL
J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e733-e735. PubMed ID: 34243220
[No Abstract] [Full Text] [Related]
4. Autoimmune skin disorders and SARS-CoV-2 vaccination - a meta-analysis.
Hinterseher J; Hertl M; Didona D
J Dtsch Dermatol Ges; 2023 Aug; 21(8):853-861. PubMed ID: 37218538
[TBL] [Abstract][Full Text] [Related]
5. Subacute cutaneous lupus erythematosus after COVID-19 vaccine.
Wang YJ; Hui HZ; Cheng JR; Mao H; Shi BJ
Int J Rheum Dis; 2023 Jul; 26(7):1407-1409. PubMed ID: 36880735
[No Abstract] [Full Text] [Related]
6. Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
Abbasi J
JAMA; 2021 Oct; 326(14):1365. PubMed ID: 34636872
[No Abstract] [Full Text] [Related]
7. Exacerbation of Chronic Cutaneous Lupus Erythematosus Triggered by Vaccine Against COVID-19.
Souza EN; Diniz LM; Moura LAD; Oliosi AC
Actas Dermosifiliogr; 2024 Apr; 115(4):T430-T432. PubMed ID: 38325543
[No Abstract] [Full Text] [Related]
8. Exacerbation of Chronic Cutaneous Lupus Erythematosus Triggered by Vaccine Against COVID-19.
Souza EN; Diniz LM; Moura LAD; Oliosi AC
Actas Dermosifiliogr; 2024 Apr; 115(4):430-432. PubMed ID: 36511288
[No Abstract] [Full Text] [Related]
9. COVID-19 vaccine-induced cutaneous lupus erythematosus.
Famularo G; Patti AL; Macciomei MC
Dermatol Online J; 2023 Oct; 29(5):. PubMed ID: 38478656
[No Abstract] [Full Text] [Related]
10. Letter to the editor regarding the article ''Patil S, Patil A. Systemic lupus erythematosus after COVID-19 vaccination: A case report. J Cosmet Dermatol. 2021 Aug 21. 10.1111/jocd.14386".
Abdullah L; Awada B; Kurban M; Abbas O
J Cosmet Dermatol; 2021 Dec; 20(12):4076-4077. PubMed ID: 34699662
[No Abstract] [Full Text] [Related]
11. New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination.
Zavala-Miranda MF; González-Ibarra SG; Pérez-Arias AA; Uribe-Uribe NO; Mejia-Vilet JM
Kidney Int; 2021 Dec; 100(6):1340-1341. PubMed ID: 34560139
[No Abstract] [Full Text] [Related]
12. Systemic lupus erythematosus after COVID-19 vaccination: A case report.
Patil S; Patil A
J Cosmet Dermatol; 2021 Oct; 20(10):3103-3104. PubMed ID: 34418261
[No Abstract] [Full Text] [Related]
13. Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series.
Assawasaksakul T; Sathitratanacheewin S; Vichaiwattana P; Wanlapakorn N; Poovorawan Y; Kittanamongkolchai W
RMD Open; 2021 Dec; 7(3):. PubMed ID: 34862313
[TBL] [Abstract][Full Text] [Related]
14. Unusual coexistence of systemic lupus erythematosus and primary biliary cirrhosis.
Nachbar F; Korting HC; Hoffmann RM; Kollmann M; Meurer M
Dermatology; 1994; 188(4):313-7. PubMed ID: 8193407
[TBL] [Abstract][Full Text] [Related]
15. An ocular adverse event in temporal association with COVID-19 vaccination in a patient with systemic lupus erythematosus: a case report.
Jin W; Tang Y; Wen C
Hum Vaccin Immunother; 2021 Nov; 17(11):4102-4104. PubMed ID: 34617875
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case.
Ceccarelli F; Olivieri G; Natalucci F; Alessandri C; Conti F
Lupus; 2021 Sep; 30(10):1698-1699. PubMed ID: 34192958
[No Abstract] [Full Text] [Related]
17. Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination.
Lee SK; Kwon JH; Yoon N; Lee SH; Sung PS
J Hepatol; 2022 Oct; 77(4):1209-1211. PubMed ID: 35817223
[No Abstract] [Full Text] [Related]
18. Subacute cutaneous lupus erythematosus induced by Pfizer COVID-19 vaccine.
Magnaterra E; Magliulo M; Mariotti EB; Ruffo DI Calabria V; Quintarelli L; Corrà A; Aimo C; Verdelli A; Caproni M
Ital J Dermatol Venerol; 2023 Jun; 158(3):266-267. PubMed ID: 36881332
[No Abstract] [Full Text] [Related]
19. Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus.
Ntouros PA; Vlachogiannis NI; Pappa M; Nezos A; Mavragani CP; Tektonidou MG; Souliotis VL; Sfikakis PP
Clin Immunol; 2021 Aug; 229():108765. PubMed ID: 34089859
[TBL] [Abstract][Full Text] [Related]
20. Forms of cholangitis to be considered after SARS-CoV-2 infection.
Cho JY; Lee YS; Kim SS; Song DS; Lee JH; Kim JH
Clin Mol Hepatol; 2022 Oct; 28(4):929-930. PubMed ID: 36096495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
